Medicus Pharma Ltd.
MDCX.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.49M | -15.83M | -13.29M | -9.89M | -9.00M |
| Total Depreciation and Amortization | -78.40K | -78.40K | -78.40K | -78.40K | -- |
| Total Amortization of Deferred Charges | 111.70K | 111.70K | -- | -- | -- |
| Total Other Non-Cash Items | 16.18M | 696.70K | 1.05M | 981.70K | -173.90K |
| Change in Net Operating Assets | -1.16M | -677.20K | -770.50K | -1.33M | -1.27M |
| Cash from Operations | -19.43M | -15.78M | -13.09M | -10.32M | -10.44M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.62M | -- | -- | -- | -- |
| Cash from Investing | -4.62M | -- | -- | -- | -- |
| Total Debt Issued | 11.87M | 4.50M | 5.17M | 5.17M | 5.17M |
| Total Debt Repaid | -5.60M | 35.00K | 35.00K | 35.00K | -- |
| Issuance of Common Stock | 21.83M | 12.82M | 11.30M | 7.52M | 5.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -680.50K | -311.80K | 15.60K | 40.60K | -- |
| Cash from Financing | 27.41M | 17.04M | 16.53M | 12.77M | 10.64M |
| Foreign Exchange rate Adjustments | -1.70K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.36M | 1.26M | 3.44M | 2.45M | 198.30K |